Creative Biolabs has long-term devoted to the development and application of immune checkpoint inhibitor (ICI) against various tumors. In order to further improve the efficacy and avoid severe immune-related adverse events (irAEs), we now provide novel biomarker development services for immune checkpoint inhibitors (ICIs). Biomarker Development for Immune Checkpoint Inhibitor immune-checkpoint.creative-biolabs.com/biomarker-development-for-immune-checkpoint-inhibitor-ici.htm